| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | polypeptide N-acetylgalactosaminyltransferase activity | 4.79e-07 | 20 | 163 | 5 | GO:0004653 | |
| GeneOntologyMolecularFunction | glucokinase activity | 5.28e-06 | 5 | 163 | 3 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 5.28e-06 | 5 | 163 | 3 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 5.28e-06 | 5 | 163 | 3 | GO:0008865 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 9.08e-06 | 35 | 163 | 5 | GO:0008376 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.18e-04 | 230 | 163 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.28e-04 | 182 | 163 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.38e-04 | 184 | 163 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | D-glucose binding | 1.82e-04 | 14 | 163 | 3 | GO:0005536 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.65e-04 | 153 | 163 | 7 | GO:0008194 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.49e-04 | 211 | 163 | 8 | GO:0016758 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | BEST1 TRPM2 RYR1 KCNG2 CLCN7 KCNG1 KCNH1 KCNK15 SCN4A SCN5A SCN10A KCNH5 | 4.00e-04 | 459 | 163 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | gated channel activity | BEST1 TRPM2 RYR1 KCNG2 CLCN7 KCNG1 KCNH1 KCNK15 SCN10A KCNH5 | 4.32e-04 | 334 | 163 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPM2 RYR1 KCNG2 KCNG1 KCNH1 KCNK15 SCN4A SCN5A SCN10A KCNH5 | 5.31e-04 | 343 | 163 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | GALNT15 GALNT3 GALNT12 B3GNT3 GALNTL5 UGGT2 GALNT5 FUT8 GALNT4 | 6.16e-04 | 288 | 163 | 9 | GO:0016757 |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 6.37e-04 | 21 | 163 | 3 | GO:0019200 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 6.61e-04 | 85 | 163 | 5 | GO:0008135 | |
| GeneOntologyMolecularFunction | tRNA binding | 7.35e-04 | 87 | 163 | 5 | GO:0000049 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 7.93e-04 | 51 | 163 | 4 | GO:0003743 | |
| GeneOntologyMolecularFunction | sodium channel activity | 8.54e-04 | 52 | 163 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 9.72e-04 | 6 | 163 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.21e-03 | 26 | 163 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | channel activity | BEST1 TRPM2 RYR1 KCNG2 CLCN7 KCNG1 KCNH1 KCNK15 SCN4A SCN5A SCN10A KCNH5 | 1.29e-03 | 525 | 163 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | BEST1 TRPM2 RYR1 KCNG2 CLCN7 KCNG1 KCNH1 KCNK15 SCN4A SCN5A SCN10A KCNH5 | 1.31e-03 | 526 | 163 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.50e-03 | 102 | 163 | 5 | GO:0005249 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 1.51e-03 | 28 | 163 | 3 | GO:0005251 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC39A9 TRPM2 RYR1 KCNG2 KCNG1 KCNH1 KCNK15 SCN4A SCN5A SCN10A KCNH5 | 1.56e-03 | 465 | 163 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.57e-03 | 152 | 163 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 2.27e-03 | 112 | 163 | 5 | GO:0090079 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 2.30e-03 | 9 | 163 | 2 | GO:0036408 | |
| GeneOntologyBiologicalProcess | O-glycan processing | 1.06e-06 | 43 | 163 | 6 | GO:0016266 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | DPP6 BEST1 NOL3 SLC39A9 SLC26A2 PDPK1 TRPM2 CHD7 RYR1 KCNG2 CLCN7 KCNG1 KCNH1 PIK3CG KCNK15 SCN4A SCN5A SCN10A MICU2 AGRN KCNH5 GP5 | 1.74e-05 | 1017 | 163 | 22 | GO:0098660 |
| GeneOntologyBiologicalProcess | carbohydrate phosphorylation | 4.18e-05 | 25 | 163 | 4 | GO:0046835 | |
| GeneOntologyBiologicalProcess | metal ion transport | DPP6 BEST1 NOL3 SLC39A9 PDPK1 TRPM2 CHD7 GCK RYR1 KCNG2 KCNG1 KCNH1 PIK3CG KCNK15 SCN4A SCN5A SCN10A MICU2 AGRN KCNH5 GP5 | 4.23e-05 | 1000 | 163 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | DPP6 BEST1 NOL3 SLC39A9 SLC26A2 PDPK1 TRPM2 CHD7 RYR1 KCNG2 CLCN7 KCNG1 KCNH1 PIK3CG KCNK15 SCN4A SCN5A SCN10A MICU2 AGRN KCNH5 GP5 | 6.91e-05 | 1115 | 163 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | hexose metabolic process | 9.05e-05 | 284 | 163 | 10 | GO:0019318 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | HK2 NOL3 SLC39A9 PDPK1 TRPM2 HKDC1 CHD7 GCK MON1A MINPP1 RYR1 GRID2IP DGAT2 KCNH1 PIK3R1 CST2 ALAS2 CROCC MICU2 GP5 | 9.77e-05 | 981 | 163 | 20 | GO:0019725 |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | GALNT15 HK2 GALNT3 HKDC1 GALNT12 GPAM SLC35B2 GCK B3GNT3 ENO4 PIGT TKFC CHST15 DGAT2 CST2 AHCY GALNTL5 UGGT2 GALNT5 NME3 FUT8 GALNT4 TRMT12 | 9.98e-05 | 1226 | 163 | 23 | GO:1901135 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | DPP6 NOL3 SLC39A9 PDPK1 TRPM2 CHD7 RYR1 KCNG2 KCNG1 KCNH1 PIK3CG KCNK15 SCN4A SCN5A SCN10A MICU2 AGRN KCNH5 GP5 | 1.29e-04 | 922 | 163 | 19 | GO:0098662 |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | GALNT15 GALNT3 GALNT12 SLC35B2 B3GNT3 CHST15 GALNTL5 UGGT2 GALNT5 FUT8 GALNT4 | 1.32e-04 | 357 | 163 | 11 | GO:0009101 |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | GALNT15 GALNT3 GALNT12 SLC35B2 B3GNT3 CHST15 CST2 GALNTL5 UGGT2 GALNT5 FUT8 GALNT4 | 1.65e-04 | 430 | 163 | 12 | GO:0009100 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | DPP6 NOL3 SLC39A9 PDPK1 TRPM2 CHD7 RYR1 KCNG2 KCNG1 KCNH1 PIK3CG KCNK15 SCN4A SCN5A SCN10A MICU2 AGRN KCNH5 GP5 | 1.69e-04 | 942 | 163 | 19 | GO:0098655 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | HK2 NOL3 SLC39A9 PDPK1 TRPM2 HKDC1 CHD7 GCK MON1A MINPP1 RYR1 GRID2IP DGAT2 KCNH1 PIK3R1 ALAS2 MICU2 GP5 | 1.76e-04 | 866 | 163 | 18 | GO:0055082 |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | GALNT15 GALNT3 GALNT12 B3GNT3 GALNTL5 UGGT2 GALNT5 FUT8 GALNT4 | 1.84e-04 | 252 | 163 | 9 | GO:0043413 |
| GeneOntologyBiologicalProcess | protein glycosylation | GALNT15 GALNT3 GALNT12 B3GNT3 GALNTL5 UGGT2 GALNT5 FUT8 GALNT4 | 1.84e-04 | 252 | 163 | 9 | GO:0006486 |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 1.85e-04 | 310 | 163 | 10 | GO:0005996 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation | 1.88e-04 | 105 | 163 | 6 | GO:0006493 | |
| GeneOntologyBiologicalProcess | glycosylation | GALNT15 GALNT3 GALNT12 B3GNT3 GALNTL5 UGGT2 GALNT5 FUT8 GALNT4 | 3.06e-04 | 270 | 163 | 9 | GO:0070085 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | DPP6 BEST1 NOL3 SLC39A9 PDPK1 TRPM2 CHD7 GCK RYR1 KCNG2 KCNG1 KCNH1 PIK3CG KCNK15 SCN4A SCN5A SCN10A MICU2 AGRN KCNH5 GP5 | 3.20e-04 | 1157 | 163 | 21 | GO:0006812 |
| GeneOntologyBiologicalProcess | potassium ion transport | 3.23e-04 | 272 | 163 | 9 | GO:0006813 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | DPP6 BEST1 RYR1 KCNG2 CLCN7 KCNG1 KCNH1 KCNK15 SCN4A SCN5A SCN10A MICU2 KCNH5 | 8.23e-06 | 378 | 162 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | cation channel complex | 1.55e-05 | 235 | 162 | 10 | GO:0034703 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | DPP6 BEST1 BCS1L RYR1 KCNG2 CLCN7 KCNG1 KCNH1 KCNK15 SCN4A SCN5A SCN10A MICU2 KCNH5 | 5.93e-05 | 523 | 162 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | DPP6 BEST1 BCS1L RYR1 KCNG2 CLCN7 KCNG1 KCNH1 KCNK15 SCN4A SCN5A SCN10A MICU2 KCNH5 | 1.01e-04 | 550 | 162 | 14 | GO:1990351 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.87e-04 | 17 | 162 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum membrane | 3.54e-04 | 4 | 162 | 2 | GO:1990578 | |
| GeneOntologyCellularComponent | membrane protein complex | DPP6 BEST1 GOSR1 NAPG BCS1L RYR1 DIPK2A KCNG2 PIGT CLCN7 KCNG1 KCNH1 PIK3CG PIK3R1 KCNK15 SYNE2 SCN4A SCN5A SCN10A MICU2 PLEKHA7 IL23R KCNH5 GP5 | 5.44e-04 | 1498 | 162 | 24 | GO:0098796 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 7.14e-04 | 91 | 162 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 2 complex | 8.77e-04 | 6 | 162 | 2 | GO:0005850 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.22e-03 | 7 | 162 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | potassium channel complex | 1.30e-03 | 104 | 162 | 5 | GO:0034705 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.44e-03 | 29 | 162 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | germ plasm | 1.44e-03 | 29 | 162 | 3 | GO:0060293 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.44e-03 | 29 | 162 | 3 | GO:0097038 | |
| GeneOntologyCellularComponent | pole plasm | 1.44e-03 | 29 | 162 | 3 | GO:0045495 | |
| GeneOntologyCellularComponent | P granule | 1.44e-03 | 29 | 162 | 3 | GO:0043186 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 1.62e-03 | 8 | 162 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 2.07e-03 | 9 | 162 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 2.07e-03 | 9 | 162 | 2 | GO:0005943 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.10e-03 | 33 | 162 | 3 | GO:0043083 | |
| HumanPheno | Abnormality of jaw muscles | 1.62e-06 | 31 | 63 | 6 | HP:0045037 | |
| HumanPheno | Abnormality of masticatory muscle | 1.61e-05 | 27 | 63 | 5 | HP:0410011 | |
| HumanPheno | Proximal muscle weakness in upper limbs | 1.69e-05 | 68 | 63 | 7 | HP:0008997 | |
| HumanPheno | Abnormal blood cation concentration | GALNT3 OBSCN CHD7 TERT BCS1L PLEKHM1 RYR1 PIGT SARS2 CLCN7 CYP2R1 PIK3CG SCN4A SCN5A SCN10A ALAS2 | 1.88e-05 | 401 | 63 | 16 | HP:0010929 |
| HumanPheno | Loss of teeth | 6.23e-05 | 57 | 63 | 6 | HP:0000701 | |
| HumanPheno | Premature loss of teeth | 6.23e-05 | 57 | 63 | 6 | HP:0006480 | |
| HumanPheno | Abnormal blood ion concentration | GALNT3 OBSCN CHD7 TERT BCS1L PLEKHM1 RYR1 PIGT SARS2 CLCN7 CYP2R1 PIK3CG SCN4A SCN5A SCN10A ALAS2 | 6.79e-05 | 445 | 63 | 16 | HP:0003111 |
| Domain | Glycos_transf_2 | 1.94e-07 | 30 | 162 | 6 | PF00535 | |
| Domain | Glyco_trans_2-like | 1.94e-07 | 30 | 162 | 6 | IPR001173 | |
| Domain | Ion_trans_dom | 6.62e-07 | 114 | 162 | 9 | IPR005821 | |
| Domain | Ion_trans | 6.62e-07 | 114 | 162 | 9 | PF00520 | |
| Domain | Ricin_B_lectin | 2.13e-06 | 25 | 162 | 5 | PF00652 | |
| Domain | RICIN | 3.86e-06 | 28 | 162 | 5 | SM00458 | |
| Domain | RICIN_B_LECTIN | 3.86e-06 | 28 | 162 | 5 | PS50231 | |
| Domain | Ricin_B_lectin | 5.52e-06 | 30 | 162 | 5 | IPR000772 | |
| Domain | Hexokinase_2 | 6.32e-06 | 5 | 162 | 3 | PF03727 | |
| Domain | Hexokinase_BS | 6.32e-06 | 5 | 162 | 3 | IPR019807 | |
| Domain | Hexokinase_C | 6.32e-06 | 5 | 162 | 3 | IPR022673 | |
| Domain | Hexokinase_N | 6.32e-06 | 5 | 162 | 3 | IPR022672 | |
| Domain | Hexokinase_1 | 6.32e-06 | 5 | 162 | 3 | PF00349 | |
| Domain | HEXOKINASE_2 | 6.32e-06 | 5 | 162 | 3 | PS51748 | |
| Domain | HEXOKINASE_1 | 6.32e-06 | 5 | 162 | 3 | PS00378 | |
| Domain | Hexokinase | 1.26e-05 | 6 | 162 | 3 | IPR001312 | |
| Domain | Na_channel_asu | 7.35e-05 | 10 | 162 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 7.35e-05 | 10 | 162 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 7.35e-05 | 10 | 162 | 3 | PF06512 | |
| Domain | - | 7.36e-05 | 81 | 162 | 6 | 3.90.550.10 | |
| Domain | K_chnl_volt-dep_EAG | 7.48e-05 | 2 | 162 | 2 | IPR003949 | |
| Domain | Nucleotide-diphossugar_trans | 1.17e-04 | 88 | 162 | 6 | IPR029044 | |
| Domain | IQ_motif_EF-hand-BS | 1.32e-04 | 90 | 162 | 6 | IPR000048 | |
| Domain | Channel_four-helix_dom | 1.34e-04 | 57 | 162 | 5 | IPR027359 | |
| Domain | - | 1.34e-04 | 57 | 162 | 5 | 1.20.120.350 | |
| Domain | IQ | 1.59e-04 | 93 | 162 | 6 | PS50096 | |
| Domain | K_chnl_volt-dep_Kv6 | 2.23e-04 | 3 | 162 | 2 | IPR003969 | |
| Domain | IQ | 3.79e-04 | 71 | 162 | 5 | PF00612 | |
| Domain | IQ | 6.95e-04 | 81 | 162 | 5 | SM00015 | |
| Domain | HAT_MYST-type | 7.35e-04 | 5 | 162 | 2 | IPR002717 | |
| Domain | MOZ_SAS | 7.35e-04 | 5 | 162 | 2 | PF01853 | |
| Domain | MYST_HAT | 7.35e-04 | 5 | 162 | 2 | PS51726 | |
| Domain | MA3 | 1.10e-03 | 6 | 162 | 2 | SM00544 | |
| Domain | MA3 | 1.10e-03 | 6 | 162 | 2 | PF02847 | |
| Domain | Initiation_fac_eIF4g_MI | 1.10e-03 | 6 | 162 | 2 | IPR003891 | |
| Domain | - | 1.10e-03 | 6 | 162 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 1.10e-03 | 6 | 162 | 2 | PF00930 | |
| Domain | MI | 1.10e-03 | 6 | 162 | 2 | PS51366 | |
| Domain | Peptidase_S9B_N | 1.10e-03 | 6 | 162 | 2 | IPR002469 | |
| Domain | eIF5C | 1.53e-03 | 7 | 162 | 2 | SM00515 | |
| Domain | W2 | 1.53e-03 | 7 | 162 | 2 | PF02020 | |
| Domain | W2 | 1.53e-03 | 7 | 162 | 2 | PS51363 | |
| Domain | W2_domain | 1.53e-03 | 7 | 162 | 2 | IPR003307 | |
| Pathway | KEGG_O_GLYCAN_BIOSYNTHESIS | 2.59e-07 | 30 | 129 | 6 | M6929 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.18e-06 | 60 | 129 | 7 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.48e-06 | 62 | 129 | 7 | M546 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | HK2 SLC26A2 HKDC1 SLC35B2 GCK RPS27A B3GNT3 ENO4 TKFC CHST15 PGP AGRN | 1.31e-05 | 288 | 129 | 12 | M16864 |
| Pathway | BIOCARTA_IGF1MTOR_PATHWAY | 2.89e-05 | 20 | 129 | 4 | MM1496 | |
| Pathway | BIOCARTA_MTOR_PATHWAY | 4.31e-05 | 22 | 129 | 4 | M16563 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 6.17e-05 | 24 | 129 | 4 | M4791 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.27e-05 | 109 | 129 | 7 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.04e-05 | 111 | 129 | 7 | M27416 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.93e-04 | 271 | 129 | 10 | MM15406 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 2.53e-04 | 14 | 129 | 3 | M16884 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 2.53e-04 | 14 | 129 | 3 | MM1485 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO7A UBR4 KAT6A INTS1 OBSCN KDM3B LAMA5 CBLC TMCO6 ZBTB42 PLEKHM1 RYR1 TKFC SARS2 CLCN7 CHST15 KCNG1 SLC25A39 KLHL21 SCN5A EIF4G1 HELZ2 ANKRD34A LRP4 TANC1 AGRN IGSF3 | 3.87e-12 | 1105 | 167 | 27 | 35748872 |
| Pubmed | 1.40e-09 | 24 | 167 | 6 | 31882545 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 1.94e-08 | 36 | 167 | 6 | 25615642 | |
| Pubmed | 3.76e-08 | 40 | 167 | 6 | 22643896 | ||
| Pubmed | 9.49e-08 | 24 | 167 | 5 | 31740596 | ||
| Pubmed | 9.61e-08 | 214 | 167 | 10 | 22199357 | ||
| Pubmed | HK2 CAPN2 KAT6A USP24 KDM3B GALNT12 GCK B3GNT3 FRK DPP9 KCNG1 KCNH1 AHCY GALNT5 KAT6B GALNT4 KCNH5 | 9.84e-08 | 730 | 167 | 17 | 34857952 | |
| Pubmed | GALNT15 ACAP1 KAT6A HKDC1 CHD7 FRK PIK3CG PIK3R1 MKI67 KCNH5 KLB | 3.82e-07 | 313 | 167 | 11 | 20800603 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO7A TAS1R3 UBR4 INTS1 OBSCN GPAM TUFM RYR1 RDH16 H4C1 KCNG1 ZFR2 VPS13A LRRC7 ARHGAP20 GP5 | 5.94e-07 | 736 | 167 | 16 | 29676528 |
| Pubmed | GALNT3 NOP53 GOSR1 INTS1 LAMA5 TMEM214 CHD7 SSRP1 PNKD TUFM MRM3 PIGT EIF2S3 EIF4G1 HELZ2 TANC1 EIF4G3 CROCC NME3 MICU2 FUT8 PLEKHA7 AGRN | 8.83e-07 | 1497 | 167 | 23 | 31527615 | |
| Pubmed | MYO1C NOP53 GOSR1 KDM3B RPS27A TUFM VPS52 KIN H4C1 EIF2S3 VPS13A MKI67 EIF4G3 RPL6 IGSF3 XPO7 | 1.20e-06 | 777 | 167 | 16 | 35844135 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | MYO1C SLC39A9 GOSR1 INTS1 LAMA5 HKDC1 TMEM214 RPS27A BCS1L TUFM MAGI2 MRM3 PIGT THOP1 DPP9 CST2 UGGT2 NME3 FUT8 AGRN MOCS1 XPO7 | 1.94e-06 | 1451 | 167 | 22 | 30550785 |
| Pubmed | 3.51e-06 | 22 | 167 | 4 | 25107907 | ||
| Pubmed | MYO1C NOP53 UBR4 INTS1 USP24 CHD7 TUFM SYNE2 EIF4G1 HELZ2 MKI67 EIF4G3 RPL6 XPO7 | 3.63e-06 | 653 | 167 | 14 | 22586326 | |
| Pubmed | ACAP1 HK2 MYO1C GOSR1 UBR4 INTS1 RPS27A TUFM PCYOX1L PIGT CLCN7 H4C1 PIK3CG PIK3R1 EIF4G1 HELZ2 MKI67 FUT8 RPL6 | 3.79e-06 | 1168 | 167 | 19 | 19946888 | |
| Pubmed | 5.98e-06 | 8 | 167 | 3 | 11159923 | ||
| Pubmed | 8.94e-06 | 9 | 167 | 3 | 16382098 | ||
| Pubmed | 1.27e-05 | 10 | 167 | 3 | 22855790 | ||
| Pubmed | Proteomics identifies the developmental regulation of HKDC1 in liver of pigs and mice. | 1.27e-05 | 10 | 167 | 3 | 37545422 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | FAM234B HK2 CAPN2 UBR4 USP24 GALNT12 SLC35B2 TMEM214 TUFM DIPK2A VPS52 EIF4G1 UGGT2 EIF4G3 FUT8 XPO7 | 1.36e-05 | 942 | 167 | 16 | 31073040 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SLC26A2 NOP53 GOSR1 INTS1 NAPG GALNT12 TMEM214 PNKD PIGT TKFC SARS2 CLCN7 EIF2S3 VPS13A UGGT2 NME3 FUT8 | 1.54e-05 | 1061 | 167 | 17 | 33845483 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FAM234B GALNT3 GOSR1 LAMA5 SLC35B2 TMEM214 MINPP1 DIPK2A PCYOX1L PIGT LRP4 UGGT2 EIF4G3 NME3 FUT8 AGRN GALNT4 IGSF3 | 2.07e-05 | 1201 | 167 | 18 | 35696571 |
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 2.29e-05 | 2 | 167 | 2 | 24642470 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 30466404 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24012746 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 33594203 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 15047701 | ||
| Pubmed | Functional distinction of human EAG1 and EAG2 potassium channels. | 2.29e-05 | 2 | 167 | 2 | 11943152 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 31999954 | ||
| Pubmed | Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. | 2.29e-05 | 2 | 167 | 2 | 17586728 | |
| Pubmed | Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells. | 2.29e-05 | 2 | 167 | 2 | 23523645 | |
| Pubmed | Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses. | 2.29e-05 | 2 | 167 | 2 | 22854782 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 21915857 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 11834499 | ||
| Pubmed | eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. | 2.29e-05 | 2 | 167 | 2 | 10872469 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 15741161 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 28150740 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 39505971 | ||
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 2.29e-05 | 2 | 167 | 2 | 24998131 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24360055 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24150941 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 32330377 | ||
| Pubmed | The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas. | 2.29e-05 | 2 | 167 | 2 | 15679862 | |
| Pubmed | Antidepressant-like effect of valproic acid-Possible involvement of PI3K/Akt/mTOR pathway. | 2.29e-05 | 2 | 167 | 2 | 28408298 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 23143475 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 18230682 | ||
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 2.29e-05 | 2 | 167 | 2 | 30944319 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 27185879 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 9446654 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 31292628 | ||
| Pubmed | Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions. | 2.29e-05 | 2 | 167 | 2 | 17302605 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 36609795 | ||
| Pubmed | Important roles of PI3Kgamma in osteoclastogenesis and bone homeostasis. | 2.29e-05 | 2 | 167 | 2 | 20616072 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 18245521 | ||
| Pubmed | Roles of surface residues of intracellular domains of heag potassium channels. | 2.29e-05 | 2 | 167 | 2 | 19172261 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 8313897 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 21885656 | ||
| Pubmed | MAGI1 copy number variation in bipolar affective disorder and schizophrenia. | 2.29e-05 | 2 | 167 | 2 | 22381734 | |
| Pubmed | Eag1 and Bestrophin 1 are up-regulated in fast-growing colonic cancer cells. | 2.29e-05 | 2 | 167 | 2 | 18222922 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 27323778 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 27380275 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 19303856 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 35187889 | ||
| Pubmed | Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. | 2.29e-05 | 2 | 167 | 2 | 18511807 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17630431 | ||
| Pubmed | Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain. | 2.29e-05 | 2 | 167 | 2 | 16325480 | |
| Pubmed | 2.32e-05 | 12 | 167 | 3 | 32492036 | ||
| Pubmed | 4.10e-05 | 40 | 167 | 4 | 16382104 | ||
| Pubmed | PDPK1 CAPN2 UBR4 BCS1L MRM3 PIGT SARS2 PIK3R1 VPS13A EIF4G3 MICU2 | 4.28e-05 | 515 | 167 | 11 | 31617661 | |
| Pubmed | 4.74e-05 | 15 | 167 | 3 | 23782696 | ||
| Pubmed | 5.76e-05 | 274 | 167 | 8 | 34244482 | ||
| Pubmed | ZNF536 GALNT3 MYO7A UBR4 USP24 KDM3B CHD7 RYR1 PIGT SYNE2 VPS13A IGSF3 | 6.51e-05 | 638 | 167 | 12 | 31182584 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 20212144 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 20116193 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 24244707 | ||
| Pubmed | Wnt/β-Catenin Signaling Exacerbates Keloid Cell Proliferation by Regulating Telomerase. | 6.85e-05 | 3 | 167 | 2 | 27771714 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 21969364 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 26462735 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 34166715 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 23063713 | ||
| Pubmed | Expression of beta-catenin in developing auditory epithelia of mice. | 6.85e-05 | 3 | 167 | 2 | 15078071 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 9857202 | ||
| Pubmed | Galpha q inhibits cardiac L-type Ca2+ channels through phosphatidylinositol 3-kinase. | 6.85e-05 | 3 | 167 | 2 | 16186103 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 25998140 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 24698832 | ||
| Pubmed | MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | 6.85e-05 | 3 | 167 | 2 | 36754959 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 17050716 | ||
| Pubmed | [Expression and significance of hTERT, c-myc and Ki-67 in hepatocellular carcinoma]. | 6.85e-05 | 3 | 167 | 2 | 19351506 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 36823376 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 17267763 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 10579793 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 18495460 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 20361045 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 20038812 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 16699071 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 24307508 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 21572399 | ||
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 15976448 | ||
| Pubmed | Modulation of skeletal and cardiac voltage-gated sodium channels by calmodulin. | 6.85e-05 | 3 | 167 | 2 | 15746172 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 17595318 | ||
| Interaction | TOP3B interactions | MYO1C MYO7A UBR4 KAT6A INTS1 OBSCN KDM3B LAMA5 CBLC TMCO6 SSRP1 ZBTB42 PLEKHM1 TUFM RYR1 TKFC SARS2 CLCN7 CHST15 KCNG1 SLC25A39 KLHL21 SCN5A EIF4G1 HELZ2 ANKRD34A LRP4 TANC1 AGRN IGSF3 | 1.69e-06 | 1470 | 161 | 30 | int:TOP3B |
| Interaction | PDGFRA interactions | MYO1C PRSS12 LAMA5 GALNT12 MINPP1 B3GNT3 TERT PIK3R1 UGGT2 GALNT5 FUT8 AGRN PLTP | 1.37e-05 | 385 | 161 | 13 | int:PDGFRA |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 1.69e-04 | 422 | 167 | 8 | chr20q13 | |
| Cytoband | 17p13.3 | 3.10e-04 | 88 | 167 | 4 | 17p13.3 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 1.60e-09 | 20 | 110 | 6 | 433 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.79e-05 | 9 | 110 | 3 | 1203 | |
| GeneFamily | Potassium voltage-gated channels | 1.00e-04 | 40 | 110 | 4 | 274 | |
| GeneFamily | CD molecules|DASH family | 7.55e-04 | 7 | 110 | 2 | 1205 | |
| Coexpression | WAGNER_APO2_SENSITIVITY | 1.18e-08 | 26 | 165 | 6 | M13240 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.06e-08 | 188 | 167 | 9 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.07e-08 | 197 | 167 | 9 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 5.30e-07 | 186 | 167 | 8 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.52e-07 | 187 | 167 | 8 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-06 | 161 | 167 | 7 | d59713ca84aa2acadfc9b3150d5f525e1b288860 | |
| ToppCell | Control-Lymphocyte-T_NK-CD4_TEM|Control / Disease, Lineage and Cell Type | 6.45e-06 | 185 | 167 | 7 | 8d6a089dcb4bfb0e74b6316fb7221688c1835e6e | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.17e-06 | 188 | 167 | 7 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.78e-06 | 125 | 167 | 6 | 43aa4b77dccf0ea2979218826af16034f2017c3a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 7.95e-06 | 191 | 167 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.95e-06 | 191 | 167 | 7 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.95e-06 | 191 | 167 | 7 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.22e-06 | 192 | 167 | 7 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.09e-06 | 195 | 167 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 195 | 167 | 7 | eaadc79f53b1cb208c6f7999925f318e1378197f | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.72e-06 | 197 | 167 | 7 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.72e-06 | 197 | 167 | 7 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.72e-06 | 197 | 167 | 7 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.72e-06 | 197 | 167 | 7 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | mild-Plasmablast|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.00e-05 | 198 | 167 | 7 | b14b9e67815f93fac7bd8e5e6f1aa100951b4ac1 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-05 | 134 | 167 | 6 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 158 | 167 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 158 | 167 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 164 | 167 | 6 | d6806deabf5f5c355934387be2baae125ac33fb8 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TEM|Leuk-UTI / Disease, Lineage and Cell Type | 3.75e-05 | 165 | 167 | 6 | 08285c09de16ed4f488abb655a22f54bc07968ae | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.02e-05 | 167 | 167 | 6 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 168 | 167 | 6 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 168 | 167 | 6 | bc7d5f0e5d222922eaf1c8e8c87aab189209d6b6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 168 | 167 | 6 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-05 | 170 | 167 | 6 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-05 | 170 | 167 | 6 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Healthy-Plasmablast|World / disease group, cell group and cell class | 5.05e-05 | 174 | 167 | 6 | 6becb456d8f44a1224c6d42be78d4c8cdb51f199 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 176 | 167 | 6 | 35610e7ac9902687e222641202409bab279c3998 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-05 | 177 | 167 | 6 | 41cbb2c109eaa7be366fc0510cce64abc06837b4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.55e-05 | 177 | 167 | 6 | 6f3b254e56e722cc23495b49e99a4abce0243cb3 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-05 | 177 | 167 | 6 | f0487e3b439f7803e465cad44916e2e271f33d6d | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 5.73e-05 | 178 | 167 | 6 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 178 | 167 | 6 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 178 | 167 | 6 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.91e-05 | 179 | 167 | 6 | dfefa4b7ae0ee50cf67e0f1938c682f08a03ec53 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.91e-05 | 179 | 167 | 6 | 64672528f73ac0921f9c7df72e14ecbfac4d5270 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-05 | 179 | 167 | 6 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-hematologic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.91e-05 | 179 | 167 | 6 | fa0dd87111d399649cdea55f2e610ebc169e8a56 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.91e-05 | 179 | 167 | 6 | 6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 6.68e-05 | 183 | 167 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 6.68e-05 | 183 | 167 | 6 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 6.88e-05 | 184 | 167 | 6 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.88e-05 | 184 | 167 | 6 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-CMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.30e-05 | 186 | 167 | 6 | 895905f1d1a01ffd5617a0baa8818693a7e9cb3b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.52e-05 | 187 | 167 | 6 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.75e-05 | 188 | 167 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-05 | 188 | 167 | 6 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.75e-05 | 188 | 167 | 6 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.75e-05 | 188 | 167 | 6 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.45e-05 | 191 | 167 | 6 | de25b2a4b5daadb05a54b1262557398da6314e7f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.45e-05 | 191 | 167 | 6 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.45e-05 | 191 | 167 | 6 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-05 | 192 | 167 | 6 | 6417468829517a0f6e04e7e44eec1622001d4c5c | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 193 | 167 | 6 | 4aee372ba2c0351b0221d0d468707d1ad21526d6 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 193 | 167 | 6 | aaa5042388dc451bff384c6bb237348f08280a08 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.21e-05 | 194 | 167 | 6 | 1eef012e53e43c4f4f6968baac3cc28727c4a9b5 | |
| ToppCell | T/NK_cells-Regulatory_T_cell|World / Lineage and Cell class | 9.21e-05 | 194 | 167 | 6 | 4f55da763f63d1bf6379582e9d85796a797c5b76 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 195 | 167 | 6 | f9a90cd7b4e99a0947fdb3645f7787d02b0f7ca0 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.47e-05 | 195 | 167 | 6 | 7ff78a46c78fe4161780930aa413e5574e05a689 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.47e-05 | 195 | 167 | 6 | bb30ac112f8c42d113fa83a9b662e40c0685bb1e | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 195 | 167 | 6 | a31a8c0e8e666acfc6737fa2c54ebd6f35605520 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.47e-05 | 195 | 167 | 6 | 48905d57775ec90cc031af0863cc8c3800f2e48e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.47e-05 | 195 | 167 | 6 | 911a37684c1f93d537f51ee71cb1ccec06840315 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Mucous-Mucous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.74e-05 | 196 | 167 | 6 | 357a5440aeebf69688bfe9fbc8585950ad00906b | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.74e-05 | 196 | 167 | 6 | 6eabbac1625f715531bae562a28da27664572600 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Mucous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.74e-05 | 196 | 167 | 6 | 98e3f9c886063def16c74ab75fc81511a7872f1c | |
| ToppCell | distal-Hematologic-B_cell|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.74e-05 | 196 | 167 | 6 | dfd2870c30b246b23bc1b3f9ad7b5d8b121238df | |
| ToppCell | tumor_Lung-T/NK_cells-CD4+_Th|tumor_Lung / Location, Cell class and cell subclass | 9.74e-05 | 196 | 167 | 6 | 42f6441505b6f04321da7953d7fe28088b8bdb89 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-04 | 197 | 167 | 6 | 749e0e332644543cbdf2ee38c2b301ce0a019a7f | |
| ToppCell | distal-Hematologic-B_cell-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.00e-04 | 197 | 167 | 6 | cc1567c3c539edc152118fb957617f8d445132d9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 197 | 167 | 6 | 38ddbfb6f6146fb9c27b2dade843a9a103e7991e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-04 | 197 | 167 | 6 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.00e-04 | 197 | 167 | 6 | 53fc73dcf93403251b5d519aa6fcfbff7240015f | |
| ToppCell | healthy_donor-Lymphocytic-T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.00e-04 | 197 | 167 | 6 | 63d0f06e150e7eb800ecb70e97b9d12a01c84e37 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.00e-04 | 197 | 167 | 6 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 198 | 167 | 6 | e63bbf0ec2a2ffe49e038a692033df71f5c8da14 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD8+_Tcm|Bac-SEP / Disease, condition lineage and cell class | 1.03e-04 | 198 | 167 | 6 | 84a07dea22b7771b34118729607b48c2d75df870 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-04 | 198 | 167 | 6 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | T/NK_cells|World / Lineage and Cell class | 1.03e-04 | 198 | 167 | 6 | c11f69b22a1ae0b371e9d0f0999716c945d0929d | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-04 | 198 | 167 | 6 | a5d66a80bbc1a5aa29d0b763ea9dc3044b8c263d | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_Tcm|Influenza_Severe / Disease, condition lineage and cell class | 1.03e-04 | 198 | 167 | 6 | fc99f2e300d76126d05c0c43e11cdbbeb74f6f0d | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.05e-04 | 124 | 167 | 5 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 1.06e-04 | 199 | 167 | 6 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| ToppCell | (22)_CD8+_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.06e-04 | 199 | 167 | 6 | e1261507f0adade3ba534d5b465c9c559fc3aed0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 167 | 6 | 0a5b842c79ec56ffd6a961f41a956b4a974d5e03 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-B-Plasmablast|ICU-SEP / Disease, condition lineage and cell class | 1.06e-04 | 199 | 167 | 6 | 09f02aaedf19f895a7b6f8eb939fd346b1df75f1 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 1.06e-04 | 199 | 167 | 6 | 6a1d84f61e1efaab541910926d6911122372659f | |
| ToppCell | droplet-Skin-nan-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 125 | 167 | 5 | 5a309ce803d2b8efd791eb21808121bf5fc3ea8e | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD4+_Tem|URO / Disease, condition lineage and cell class | 1.09e-04 | 200 | 167 | 6 | 8b7bfe6411de9528603481f6e5612cbbb8471cf6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.09e-04 | 200 | 167 | 6 | 73b91cb66c375b44e852404a4a445cf2b9595aee | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.09e-04 | 200 | 167 | 6 | e3ad8d592686a5d1e1fb8dd05c2f00eac4c5738f | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.09e-04 | 200 | 167 | 6 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK|COVID-19_Severe / Disease group, lineage and cell class | 1.09e-04 | 200 | 167 | 6 | 9fc818bf5c9133fc2fece47980e71fd3f8603558 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.09e-04 | 200 | 167 | 6 | 1cbb62df4ea1631fef8497e1702175605d0869e7 | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 1.09e-04 | 200 | 167 | 6 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 200 | 167 | 6 | f1c8780d64b58b6fb84fffbc27f0ad337b1a6e56 | |
| Drug | pyraclofos | 1.01e-06 | 106 | 164 | 8 | CID000093460 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 4.16e-07 | 28 | 162 | 5 | DOID:4194 (implicated_via_orthology) | |
| Disease | hyperinsulinemic hypoglycemia (implicated_via_orthology) | 1.61e-06 | 5 | 162 | 3 | DOID:13317 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 1.89e-05 | 10 | 162 | 3 | DOID:0050524 (implicated_via_orthology) | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 3.00e-05 | 2 | 162 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | Ventricular Fibrillation, Paroxysmal Familial, 1 | 3.00e-05 | 2 | 162 | 2 | C2751898 | |
| Disease | VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO | 3.00e-05 | 2 | 162 | 2 | C4017668 | |
| Disease | Paroxysmal familial ventricular fibrillation | 3.00e-05 | 2 | 162 | 2 | cv:C0340493 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.45e-05 | 12 | 162 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | GOSR1 CBLC GPAM MON1A FRK NPIPB8 H4C1 LIPG NPIPB6 PIK3R1 CRLF3 BTN1A1 SCN4A AHCY PGP CROCC PLTP MOG | 3.97e-05 | 1106 | 162 | 18 | EFO_0021796 |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 8.63e-05 | 16 | 162 | 3 | C0751885 | |
| Disease | Osteopetrosis, Autosomal Recessive 6 | 8.95e-05 | 3 | 162 | 2 | C1969093 | |
| Disease | Osteopetrosis - intermediate type | 8.95e-05 | 3 | 162 | 2 | C0432261 | |
| Disease | PR interval | MAGI1 OBSCN CCDC7 MAGI2 CASKIN2 SYNE2 SCN5A SCN10A KIAA1755 MICU2 XPO7 | 9.75e-05 | 495 | 162 | 11 | EFO_0004462 |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.04e-04 | 17 | 162 | 3 | C0751883 | |
| Disease | hyperglycemia (implicated_via_orthology) | 1.04e-04 | 17 | 162 | 3 | DOID:4195 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.11e-04 | 264 | 162 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.48e-04 | 19 | 162 | 3 | C0751884 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.49e-04 | 206 | 162 | 7 | EFO_0004612, EFO_0020947 | |
| Disease | Brugada ECG Pattern | 1.78e-04 | 4 | 162 | 2 | C1721096 | |
| Disease | head and neck carcinoma, lung cancer | 1.78e-04 | 4 | 162 | 2 | MONDO_0002038, MONDO_0008903 | |
| Disease | Paroxysmal familial ventricular fibrillation | 1.78e-04 | 4 | 162 | 2 | C0340493 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.66e-04 | 103 | 162 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | Osteopetrosis | 2.96e-04 | 5 | 162 | 2 | C0029454 | |
| Disease | 2-hydroxydecanoate measurement | 2.96e-04 | 5 | 162 | 2 | EFO_0800347 | |
| Disease | Myasthenic Syndromes, Congenital | 3.02e-04 | 24 | 162 | 3 | C0751882 | |
| Disease | HDL cholesterol change measurement, physical activity | 3.81e-04 | 62 | 162 | 4 | EFO_0003940, EFO_0007805 | |
| Disease | hypopituitarism (implicated_via_orthology) | 4.43e-04 | 6 | 162 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | total lipids in very large HDL measurement | 4.84e-04 | 66 | 162 | 4 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 4.84e-04 | 66 | 162 | 4 | EFO_0022298 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.58e-04 | 121 | 162 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | electrocardiography, PR interval | 6.18e-04 | 7 | 162 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | fatty liver disease (implicated_via_orthology) | 6.52e-04 | 31 | 162 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | phospholipids in large HDL measurement | 7.10e-04 | 73 | 162 | 4 | EFO_0022190 | |
| Disease | total lipids in large HDL | 7.47e-04 | 74 | 162 | 4 | EFO_0022189 | |
| Disease | sensory perception of taste | 7.85e-04 | 33 | 162 | 3 | GO_0050909 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 8.28e-04 | 274 | 162 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | Malignant neoplasm of breast | ACAP1 PDPK1 UBR4 OBSCN TERT H4C1 KCNH1 SYNE2 MKI67 ANKRD34A LRRC7 TMEM39A GALNT5 KAT6B RAD54L | 8.85e-04 | 1074 | 162 | 15 | C0006142 |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 9.11e-04 | 78 | 162 | 4 | EFO_0022187 | |
| Disease | sleep duration | 9.13e-04 | 362 | 162 | 8 | EFO_0005271 | |
| Disease | free cholesterol in large HDL measurement | 9.55e-04 | 79 | 162 | 4 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 1.00e-03 | 80 | 162 | 4 | EFO_0021900 | |
| Disease | leukodystrophy (implicated_via_orthology) | 1.05e-03 | 9 | 162 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | supraventricular ectopy | 1.05e-03 | 9 | 162 | 2 | EFO_0009277 | |
| Disease | atrial fibrillation | 1.07e-03 | 371 | 162 | 8 | EFO_0000275 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.17e-03 | 291 | 162 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | alcohol use disorder measurement | 1.21e-03 | 214 | 162 | 6 | EFO_0009458 | |
| Disease | cortical thickness | MAGI1 ZNF536 PRSS12 TM7SF3 GALNT12 CHD7 PNKD TENM2 PLEKHM1 ENO4 PIK3R1 LRP4 KIAA1755 EIF4G3 PLEKHA7 | 1.26e-03 | 1113 | 162 | 15 | EFO_0004840 |
| Disease | degree of unsaturation measurement | 1.28e-03 | 39 | 162 | 3 | EFO_0022261 | |
| Disease | PR segment | 1.31e-03 | 10 | 162 | 2 | EFO_0005095 | |
| Disease | urinary 6‑hydroxymelatonin sulfate to creatinine ratio | 1.31e-03 | 10 | 162 | 2 | EFO_0021488 | |
| Disease | resting heart rate | 1.42e-03 | 149 | 162 | 5 | EFO_0004351 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.46e-03 | 222 | 162 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | occupational attainment | 1.59e-03 | 42 | 162 | 3 | EFO_0020977 | |
| Disease | X-18913 measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0800795 | |
| Disease | Paroxysmal atrial fibrillation | 1.74e-03 | 156 | 162 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.74e-03 | 156 | 162 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.74e-03 | 156 | 162 | 5 | C2585653 | |
| Disease | Congenital myopathy (disorder) | 1.91e-03 | 12 | 162 | 2 | C0270960 | |
| Disease | Atrial Fibrillation | 1.94e-03 | 160 | 162 | 5 | C0004238 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 2.05e-03 | 162 | 162 | 5 | EFO_0004612, EFO_0007878 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 2.07e-03 | 46 | 162 | 3 | DOID:5426 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.11e-03 | 163 | 162 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Brugada Syndrome 1 | 2.25e-03 | 13 | 162 | 2 | C4551804 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 2.40e-03 | 168 | 162 | 5 | EFO_0004329, EFO_0004612 | |
| Disease | malaria | 2.45e-03 | 102 | 162 | 4 | EFO_0001068 | |
| Disease | Hamman-Rich syndrome | 2.61e-03 | 14 | 162 | 2 | C0085786 | |
| Disease | T wave morphology measurement | 2.61e-03 | 14 | 162 | 2 | EFO_0008398 | |
| Disease | Leukemia, Myelocytic, Acute | 2.72e-03 | 173 | 162 | 5 | C0023467 | |
| Disease | fatty acid measurement | 2.92e-03 | 436 | 162 | 8 | EFO_0005110 | |
| Disease | P wave duration | 3.00e-03 | 15 | 162 | 2 | EFO_0005094 | |
| Disease | Romano-Ward Syndrome | 3.42e-03 | 16 | 162 | 2 | C0035828 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 3.46e-03 | 55 | 162 | 3 | EFO_0022288 | |
| Disease | heart rate response to recovery post exercise | 3.83e-03 | 57 | 162 | 3 | EFO_0009185 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 3.86e-03 | 17 | 162 | 2 | C1839839 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 3.86e-03 | 17 | 162 | 2 | OBA_2045173 | |
| Disease | aspartate aminotransferase measurement | MAGI1 DPP6 MYO7A SLC26A2 PDPK1 OBSCN TNFRSF6B HKDC1 GPAM PLEKHM1 FRK PIK3R1 | 4.33e-03 | 904 | 162 | 12 | EFO_0004736 |
| Disease | free cholesterol in HDL measurement | 4.63e-03 | 61 | 162 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 4.63e-03 | 61 | 162 | 3 | EFO_0022293 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 4.73e-03 | 197 | 162 | 5 | EFO_0005680 | |
| Disease | Brugada syndrome | 4.82e-03 | 19 | 162 | 2 | MONDO_0015263 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 4.82e-03 | 19 | 162 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | Usual Interstitial Pneumonia | 4.82e-03 | 19 | 162 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.82e-03 | 19 | 162 | 2 | C4721508 | |
| Disease | phosphatidylcholine measurement | 4.94e-03 | 284 | 162 | 6 | EFO_0010226 | |
| Disease | total lipids in HDL measurement | 5.07e-03 | 63 | 162 | 3 | EFO_0022307 | |
| Disease | maximal midexpiratory flow rate | 5.33e-03 | 20 | 162 | 2 | EFO_0004313 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 5.33e-03 | 20 | 162 | 2 | OBA_2045071 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 5.33e-03 | 20 | 162 | 2 | C4721952 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.36e-03 | 127 | 162 | 4 | EFO_0008595, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVRLHLGFRLRIGKR | 1161 | Q68DN1 | |
| FRAGSRLRRQLAKLA | 111 | Q9ULV8 | |
| LRGALGRRLLNDEFK | 1011 | Q96M83 | |
| GIAKGRVALRIRGVR | 101 | Q13410 | |
| NALRRALRHDLGGKR | 86 | Q7RTU4 | |
| LARKGVQLGLVAFRR | 31 | Q9Y276 | |
| RVSLERNGRKGALRV | 1726 | O00468 | |
| GKDEQGRLLRRTLIR | 116 | O76090 | |
| TLVKEGLRGFREARR | 111 | Q15027 | |
| SAGRVRLHRLQLLGV | 141 | Q9H8S5 | |
| GRSLFILKLGRRSRL | 171 | Q8N4T0 | |
| RRRGRRKNVEGLDLL | 2511 | Q9P2D1 | |
| RAVGQGKLRLARLLL | 11 | Q69YU3 | |
| GRSLRERLEKIGLNL | 281 | Q92481 | |
| HFRLVLRLVLRGGRE | 166 | Q9UBG7 | |
| RILVGNRLHLAFKRQ | 121 | Q96S21 | |
| RALGLKRAGVRRALH | 96 | Q92698 | |
| VVGLLRDAIKRRGDF | 181 | P35557 | |
| RLRLGAKRAVNNGRL | 151 | Q8WYB5 | |
| FLELLRRRFGTKRVH | 76 | O60870 | |
| LRLLHRRQKRIIGGK | 621 | P56730 | |
| LVAILRIQSGEGRRK | 221 | Q8NGT7 | |
| LAAILRIQSGEGRRK | 221 | Q96R47 | |
| ARLRHQELFRLRGIK | 361 | Q9NZM5 | |
| LLALRSGAFRKRQVL | 351 | Q9NPI8 | |
| RINLRKRRDSLILGG | 221 | O95249 | |
| RRLARRGGVKRISGL | 36 | P62805 | |
| RRLARHGGVKRILGL | 36 | Q99525 | |
| IELIKNGGRRVRLFL | 1216 | Q96QZ7 | |
| IELIKSGGRRVRLLL | 1211 | Q86UL8 | |
| LQLRLLFSRRKGKGQ | 1636 | Q8N201 | |
| NFGRLVKLRILELRE | 156 | Q96NW7 | |
| GRQRLLVQKRGALRR | 36 | Q9H427 | |
| NSLLGKLELRVRLGR | 831 | Q5JYT7 | |
| VRLLRLGRVARKLDH | 326 | Q8NCM2 | |
| GVKLLRSNKRLGAIR | 251 | Q8N3T1 | |
| FTKRGLLFRGRISER | 761 | P52789 | |
| LLFRGRISERLKTRG | 766 | P52789 | |
| RVFKLFRALGLRHLV | 756 | P51798 | |
| AGRRLLKLGNVLRDF | 421 | Q8N3Y1 | |
| KLLGLRHRREVVGRS | 96 | Q8NBM8 | |
| GKALRTQLDLRRFRI | 381 | P55058 | |
| IVALLRAGKLRLLRG | 81 | Q9UJ96 | |
| LKDNLGLRHRRTGAR | 51 | Q8IYA7 | |
| TLRNREVKGALGRLL | 291 | Q7Z3T1 | |
| EALRALRARGKRLGF | 51 | A6NDG6 | |
| GHRLEGLREARRQIK | 31 | Q8IUI8 | |
| IGRGELRRFLSRIKF | 601 | A2RU67 | |
| RGNKIGLKDVITLRR | 151 | E9PQR5 | |
| LGRIFRKVGQRLLTQ | 91 | Q496M5 | |
| HFRRLIFTRKGVLRV | 941 | Q7LBC6 | |
| VRLLRLGRVARKLDH | 356 | O95259 | |
| GRELNIRRIRVKSGE | 441 | Q9Y5X9 | |
| RRRRIIINVGGIKYS | 61 | Q9UIX4 | |
| NLGALVRGLKREDLR | 321 | P49411 | |
| LKRRRVSFGGHLRPE | 501 | P46013 | |
| LLGGSRKRVLVRVER | 3031 | O15230 | |
| NLLRGKRDGTFLVRE | 636 | P27986 | |
| VKRLAELRRGLLQGE | 616 | Q8WXE0 | |
| RLLKGEEGQALRRAH | 436 | P22557 | |
| RLRGKLRAEIENLHR | 181 | Q16653 | |
| LLRIIGAAVGRKKRQ | 351 | Q9NZB8 | |
| GARDLQRGLRKGLVR | 7871 | Q5VST9 | |
| QLRLAIKRAIGHGRL | 146 | Q92794 | |
| QERLRKRGAHLALRE | 511 | Q86VX9 | |
| ACILRKNRRRVFGLL | 26 | Q9BU20 | |
| RIKRLDEGGFFLTRR | 166 | P42685 | |
| RRETLGLRQRLLKGE | 1321 | Q5TZA2 | |
| LGEVRLDKLGRTTFR | 216 | O75054 | |
| LALGRELLRLAGRKR | 111 | A4D2P6 | |
| LLRGLSQLRAERKFL | 21 | Q9UJP4 | |
| GFSHLDRRERVLKLG | 6 | Q96CJ1 | |
| ELLRERKRLGVFGIT | 126 | Q86TI2 | |
| LLFALGVRQLLKQRR | 21 | Q6VVX0 | |
| QRERKGLITARLLGA | 251 | Q14435 | |
| TNKREGLVRARLIGA | 201 | Q8N4A0 | |
| RLKERHGLIRARLAG | 561 | Q7Z7M9 | |
| EGGRRRVVLKRLGSQ | 101 | Q8NDZ4 | |
| FNRSFRTGIKRRILL | 376 | Q5VWK5 | |
| NKKREGLIRARLIGA | 201 | Q7Z4T8 | |
| RANKREGLVRARLLG | 201 | Q8IXK2 | |
| GRERKVRGLQLRLLF | 131 | Q9Y2A9 | |
| NVKLRGRLRRITENG | 76 | Q6P1S2 | |
| GRGRLFGLSVVLLKR | 296 | P0C7T7 | |
| ARRRSLGNIKFIGEL | 891 | Q04637 | |
| VRFIKLGGLSRGERV | 541 | A6NNW6 | |
| GLGKLRQVSLRRNRL | 361 | P40197 | |
| TGNRLLHRVEGVRLK | 556 | Q86Z14 | |
| GALGTKIHKLRRLRD | 46 | Q9BU64 | |
| FLLRRLLGVRTEGDK | 376 | Q2VIR3 | |
| RLLRVLRAREQIVGG | 66 | P09228 | |
| GFQGTKLLHEVRRRL | 666 | P42658 | |
| RLRGRVLGVLKRKRH | 1186 | Q9BYK8 | |
| SLRKGRLQRVGLERL | 1241 | Q9BYK8 | |
| TFLVGLIQKHRRRQR | 406 | P17655 | |
| GNLRTILLDQHRRKF | 156 | Q7Z3Z3 | |
| KNGRRIILLAEGRLV | 331 | P23526 | |
| GLERNRIRKHLLVFA | 201 | Q9NUM3 | |
| GKGEALRIRAILRSL | 2446 | P21817 | |
| RRRSIGNIKFIGELF | 886 | O43432 | |
| RGNKIGLKDVITLRR | 151 | E9PJ23 | |
| LRNRKGFVKLALRHG | 256 | Q96PD7 | |
| LAAILRIQSGEGRRK | 221 | Q8NGT9 | |
| RLVGEIVRRFERKGF | 36 | Q13232 | |
| RALGGLLKFLGRRRI | 181 | O43196 | |
| LLKFLGRRRIGVELE | 186 | O43196 | |
| NGLGKDHEILRRRIE | 106 | Q9BYC5 | |
| LLIDGRAELKRGLQR | 86 | Q9P2F6 | |
| HLIGRRREQLKLLGD | 916 | Q9Y4G2 | |
| QGLRARGREIRKELV | 136 | Q9NP81 | |
| LGGLEDHILRRKRRI | 641 | Q68CJ6 | |
| KGRGARNARVLRGIL | 11 | Q8N490 | |
| GRVLRLIRGAKGIRT | 1456 | P35499 | |
| LIRRGRTKGLIKEHE | 966 | Q8WXH0 | |
| LFRGQISERLRTRGI | 766 | Q2TB90 | |
| FREKQGKILLEGRRL | 116 | Q9HC36 | |
| SILLFEGKRQLRGRA | 396 | Q9HC36 | |
| FGKLLARQLDARGLR | 41 | O75452 | |
| RKGERVALLVTRGFR | 91 | O14841 | |
| RKGLFARRRQLLLTE | 466 | O15530 | |
| TLIHKLGGFFIRRRL | 266 | Q9HCL2 | |
| LRLLGQKFSVRARID | 626 | P98174 | |
| GKLRRGLAVSRQAVR | 16 | Q8IYU8 | |
| ALVRERKRTLGQGER | 1086 | Q6IQ23 | |
| GGQVDLFKRRVVRRL | 286 | Q9Y6U7 | |
| LALARIQRGLRFVKR | 961 | Q14524 | |
| GRILRLIRGAKGIRT | 1631 | Q14524 | |
| NLRLGVQKGVLHDRR | 251 | Q9C0D5 | |
| GRKLRVHGRNLLSID | 1836 | Q9NT68 | |
| RRVRRLLLLVQGKGE | 56 | O60936 | |
| QKRIRATTLLEGGFR | 361 | Q5VTB9 | |
| TGALRKALRGRAELV | 26 | Q8WZ82 | |
| ERGRYAKLIHNLRGL | 691 | Q96J65 | |
| GRLRLSRQGIIFKNS | 21 | Q08945 | |
| TRKRFGIVRLRDGLR | 291 | Q7LFX5 | |
| ALARFLLKRGLRNKR | 676 | P48736 | |
| LLKRGLRNKRIGHFL | 681 | P48736 | |
| IRLRNRQAVRGKLGE | 156 | Q8N1B4 | |
| VGRFNGSLRTERLKI | 471 | Q7RTX0 | |
| ILAKGLLLRGDRNVR | 661 | Q9UPR6 | |
| FIVHGRRLRIEAKER | 3121 | Q96RL7 | |
| KLRQLHGLLQARGSR | 101 | Q9UNW1 | |
| LAKRLANLIRRARGV | 561 | Q969N2 | |
| IILTGRHRGKRVVFL | 151 | Q02878 | |
| GSLRAELGKLRERLQ | 241 | Q5EBL4 | |
| LLRRIRAESGTKGLF | 306 | Q9BZJ4 | |
| LLGKASRLLVRGRRF | 156 | Q99747 | |
| ITIVNLRGALRKFRD | 486 | P50443 | |
| LLRVYARGRLKQRGK | 406 | Q8TB61 | |
| GRILRLIRAAKGIRT | 1581 | Q9Y5Y9 | |
| VLFKLLRDRIVLGRA | 461 | Q9NV64 | |
| RRRQLLTVFREGKDG | 411 | O94759 | |
| VVLRAKGLRLQEDRG | 351 | X6R8R1 | |
| RELRGIIRGLLAKAA | 176 | Q6NUQ4 | |
| KEREGALVSLRRGLQ | 81 | Q96DC7 | |
| GKGRGRVREENRLLH | 186 | O15090 | |
| HGGRLLGRLRQQREL | 6 | B2RXF5 | |
| RVRQKLLSLIGRIGR | 526 | Q9UPU5 | |
| KRTLVGLVRDLRGIA | 716 | Q9UIA9 | |
| LALGVQRLAKRGRVS | 166 | Q53H54 | |
| LIIHLKRFRQEGDRR | 641 | Q70CQ4 | |
| RRKLHRLQLDALQRG | 171 | Q9GZT5 | |
| DLKKFRRIGAGDRLR | 1396 | Q9NYU1 | |
| RSLEGRGVKIARALV | 286 | Q3LXA3 | |
| YLERLIKLGRRNGLH | 141 | P52888 | |
| RLAGIRDFKQGRHLL | 4491 | Q5T4S7 | |
| TLHLVLRLRGGAKKR | 66 | P62979 | |
| SFLQERLGIHLIRRK | 421 | Q6P2D8 | |
| NKLFAGIRRDGLLLR | 851 | O14746 | |
| AGRNMRRKLFGVLRL | 966 | O14746 | |
| LRERLYGRLTQIKGL | 541 | Q9NS93 | |
| KLRRRLTELLGAQDG | 256 | O95407 | |
| FLLRRLLGVRTEGDK | 376 | P41091 | |
| LKQLRSSRGGLLRDH | 1826 | O75096 | |
| QRTRKSLGRGEFRLL | 531 | O00159 | |
| RLGFLRLQALHRSRK | 791 | Q13402 |